Santa Farma Pharmaceuticals, one of Türkiye’s well-established pharmaceutical companies with more than 80 years of industry experience, entered the pharmaceutical sector in 1944 with the establishment of Farma Laboratory. The company subsequently embarked on a period of growth following its merger with Santa Laboratory. Santa Farma Pharmaceutical Factory Collective Company was established in 1954, followed by the incorporation of Santa Farma Pharmaceuticals Industry Inc. in 1973.

Today, Santa Farma operates in Türkiye with a portfolio comprising 74 brands and 150 products across 10 therapeutic areas: Dermatology, Musculoskeletal System, Gastrointestinal System, Urogenital System, Hematology, Cardiovascular and Cardiometabolic Systems, Central Nervous System, Endocrinology and Metabolism, Respiratory System, and Infectious Diseases.

Located in the GEBKİM Organized Industrial Zone, Santa Farma’s manufacturing facility holds EU, EAEU and ANVISA GMP certifications, enabling the development, registration and manufacture of generic pharmaceutical products for European Union member states and other regulated markets. The facility has a total enclosed area of 44,000 square metres and an annual production capacity of 150 million packs.

Guided by our mission to deliver preferred solutions that improve human health and quality of life, and driven by our commitment to “Providing Healthy Service to Health,” we continuously strive to create meaningful value in people’s lives across more than 65 countries in which we operate.